In the present study, we aimed to measure serum levels of adiponectin, an anti-inflammatory adipokine, in AD patients with varying clinical severities and compare these with those of a body mass index (BMI)-matched control group. The gene discussed is ADIPOQ; the disease is Alzheimer disease.